The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins
Abstract
Fanconi anaemia (FA) has recently become an attractive model to study breast cancer susceptibility (BRCA) genes, as three FA genes, FANCD1, FANCN and FANCJ, are identical to the BRCA genes BRCA2, PALB2 and BRIP1. Increasing evidence shows that FA proteins function as signal transducers and DNA-processing molecules in a DNA-damage response network. This network consists of many proteins that maintain genome integrity, including ataxia telangiectasia and Rad3 related protein (ATR), Bloom syndrome protein (BLM), and BRCA1. Now that the gene that is defective in the thirteenth and last assigned FA complementation group (FANCI) has been identified, I discuss what is known about FA proteins and their interactive network, and what remains to be discovered.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FA is a rare cancer-prone disease in which patients’ cells are characterized by extreme sensitivity to agents that induce DNA interstrand crosslinks (for review, see [22,23]).”
From Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1 (2011) · cites this paper as [23]
Citations
Cites
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
Hallmarks of 'BRCAness' in sporadic cancers
Turner, N. C., Tutt, A. N. J., & Ashworth, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1457 · Cited by 1,690
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Biallelic Inactivation of BRCA2 in Fanconi Anemia
Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149
Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2
Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D., Regel, E., Dinh, C. Q., Sands, A., Gregor Eichele, C., Hasty, P., & Bradley, A. (1997) · Nature · doi:10.1038/386804a0 · Cited by 1,087
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Rahman, N., Seal, S., Thompson, D. J., Kelly, P. F., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., Chagtai, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,026
BRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks
Moynahan, M. E., Pierce, A. J., & Jasin, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00174-5 · Cited by 1,007
Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2
Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861
Interaction of Human DNA Polymerase η with Monoubiquitinated PCNA
Kannouche, P. L., Wing, J., & Lehmann, A. R. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00259-x · Cited by 845
BRCA2 Function in DNA Binding and Recombination from a BRCA2-DSS1-ssDNA Structure
Yang, H., Jeffrey, P. D., Miller, J. J., Kinnucan, E., Sun, Y., Thomä, N. H., Zheng, N., Chen, P., Lee, W., & Pavletich, N. P. (2002) · Science · doi:10.1126/science.297.5588.1837 · Cited by 719
Flagged first, then by citations
Research works printed but not linked: 1
- Fanconi, G. Familiaere infantile perniziosaartige Anaemie (pernizioeses Blutbild and konstitution). Jahrbuch Kinderheild 117, 257–280 (1927) (in German).
Cited by
Sorted by citations
Items 401–500 of 662
Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones
Lee, E. Y.-H. P. (2008) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e3282f42237 · Cited by 20
The Molecular Basis of Cancer and the Development of Targeted Therapy
Riley, L. B., & Desai, D. C. (2009) · Surgical Clinics of North America · doi:10.1016/j.suc.2008.09.016 · Cited by 21
Sleeping Beauty‐mediated correction of Fanconi anemia type C
Hyland, K. A., Olson, E. R., Clark, K. J., Aronovich, E. L., Hackett, P. B., Blazar, B. R., Tolar, J., & McIvor, R. S. (2011) · The Journal of Gene Medicine · doi:10.1002/jgm.1589 · Cited by 19
Su, W., Hsu, S.-H., Wu, C.-K., Chang, S., Lin, Y.-J., Yang, W., Hung, J., Chiu, W., Tzeng, S., Tseng, Y., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2210 · Cited by 20
Su, W., Ho, Y.-C., Wu, C.-K., Hsu, S.-H., Shiu, J.-L., Huang, J.-C., Chang, S., Chiu, W., Hung, J., Liu, T.-L., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04223-5 · Cited by 19
Involvement of p29 in DNA damage responses and Fanconi anemia pathway
Chu, P., Wang, T., Lu, Y., Chou, C.-K., Yang, Y., & Chang, M.-S. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp204 · Cited by 19
Han, T.-J., Lee, C. H., Yoo, C.-W., Shin, H., Park, H., Cho, K. H., Park, J. Y., Choi, S.-W., & Kim, J. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.03.009 · Cited by 19
The Fanconi anemia pathway: Insights from somatic cell genetics using DT40 cell line
Takata, M., Ishiai, M., & Kitao, H. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.12.012 · Cited by 18
Miller, H. B., Robinson, T. J., Gordân, R., Hartemink, A. J., & García-Blanco, M. A. (2011) · RNA · doi:10.1261/rna.2462011 · Cited by 18
SCAI promotes error‐free repair of DNA interstrand crosslinks via the Fanconi anemia pathway
Schubert, L. A., Hendriks, I. A., Hertz, E. P. T., Wu, W., Sellés‐Baiget, S., Hoffmann, S., Viswalingam, K. S., Gallina, I., Pentakota, S., Benedict, B., et al. (2022) · EMBO Reports · doi:10.15252/embr.202153639 · Cited by 18
Topo IIIα and BLM Act within the Fanconi Anemia Pathway in Response to DNA-Crosslinking Agents
Hemphill, A., Akkari, Y. M. N., Newell, A. H., Schultz, R. A., Grompe, M., North, P. S., Hickson, I. D., Jakobs, P. M., Rennie, S., Pauw, D., et al. (2009) · Cytogenetic and Genome Research · doi:10.1159/000230001 · Cited by 19
Sommers, J. A., Suhasini, A. N., & Brosh, R. M. (2015) · Biomolecules · doi:10.3390/biom5020590 · Cited by 19
Tjioe, E., Berry, M. W., & Homayouni, R. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-s6-s14 · Cited by 18
Jamsai, D., O’Connor, A. E., O’Donnell, L., Lo, J. C. Y., & O’Bryan, M. K. (2014) · Spermatogenesis · doi:10.4161/21565562.2014.979061 · Cited by 18
BRCA2 Variants and cardiovascular disease in a multi-ethnic study
Zbuk, K. M., Xie, C., Young, R., Heydarpour, M., Paré, G., Davis, A. D., Miller, R., Lanktree, M. B., Saleheen, D., Danesh, J., et al. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-56 · Cited by 18
Ameziane, N., van den Ouweland, A. M. W., Adank, M. A., Vijzelaar, R., Errami, A., Dorsman, J. C., Joenje, H., Meijers-Heijboer, H. E. J., & Waisfisz, Q. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0428-8 · Cited by 19
The ubiquitin family meets the Fanconi anemia proteins
Renaudin, X., Lerner, L. K., Menck, C. F. M., & Rosselli, F. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.06.004 · Cited by 18
Chromatin Ubiquitination Guides DNA Double Strand Break Signaling and Repair
Kolobynina, K. G., Rapp, A. W., & Cardoso, M. C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.928113 · Cited by 17
Clark, D. W., Tripathi, K. K., Dorsman, J. C., & Palle, K. (2015) · Oncotarget · doi:10.18632/oncotarget.5006 · Cited by 17
Gayarre, J., Martín, P., Osório, A., Paumard‐Hernández, B., Barroso, A., Fernández, V., de la Hoya, M., Rojo‐Sebastián, A., Caldés, T., Palacios, J., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.286 · Cited by 17
Spectrin and its interacting partners in nuclear structure and function
Lambert, M. W. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370218763563 · Cited by 17
Herrmann, N. J., Knoll, A., & Puchta, H. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv208 · Cited by 16
Tumini, E., Plevani, P., Muzi-Falconi, M., & Marini, F. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.10.006 · Cited by 16
Advances in the understanding of the Fanconi anemia tumor suppressor pathway
Pickering, A., Zhang, J., Panneerselvam, J., & Fei, P. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.26380 · Cited by 18
Qian, L., Yuan, F., Rodriguez-Tello, P., Padgaonkar, S., & Zhang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082666 · Cited by 16
Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms
Baranwal, A., Hahn, C. N., Shah, M. V., & Hiwase, D. (2022) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-022-00676-2 · Cited by 16
DNA Repair and Resistance to Cancer Therapy
Antnio, S., Costa, B. A., Martins, C., Gromicho, M., Nuno, G., Patrcia, S., & Rueff, J. (2013) · InTech eBooks · doi:10.5772/53952 · Cited by 18
FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons
Kachnic, L. A., Li, L., Fournier, L., Ferraiolo, N., Dahm‐Daphi, J., Borgmann, K., & Willers, H. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.02.030 · Cited by 16
Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility
Lakhi, N. A., & Mizejewski, G. J. (2016) · Fetal and Pediatric Pathology · doi:10.1080/15513815.2016.1225873 · Cited by 16
Das, R., & Ghosh, S. K. (2017) · DNA repair · doi:10.1016/j.dnarep.2017.02.013 · Cited by 16
Breast cancer genetic susceptibility: With focus in Saudi Arabia
Alshammari, F. D. (2019) · Journal of Oncological Sciences · doi:10.1016/j.jons.2019.02.001 · Cited by 16
The Clinical Utility of Biomarkers in the Management of Pancreatic Adenocarcinoma
Jazieh, K., Foote, M. B., & Diaz, L. A. (2014) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2013.11.007 · Cited by 16
Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families
Fernández‐Rodríguez, J., Quiles, F., Blanco, I., Teulé, À., Feliubadaló, L., Valle, J. D., Salinas, M., Izquierdo, Á., Darder, E., Schindler, D., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-84 · Cited by 16
Ubiquitin control of S phase: a new role for the ubiquitin conjugating enzyme, UbcH7
Whitcomb, E. A., & Taylor, A. (2009) · Cell Division · doi:10.1186/1747-1028-4-17 · Cited by 15
Hawaii natural compounds are promising to reduce ovarian cancer deaths
Fei‐Zhang, D. J., Li, C., & Cao, S. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1178428 · Cited by 15
A Hidden Role of the Inactivated FANCD2: Upregulating ΔNp63
Panneerselvam, J., Pickering, A., Zhang, J., Wang, H., Tian, H., Zheng, J., & Fei, P. (2013) · Oncotarget · doi:10.18632/oncotarget.1217 · Cited by 15
Inherited bone marrow failure syndromes
Dokal, I. S. (2011) · Journal of Hematopathology · doi:10.1007/s12308-011-0089-5 · Cited by 15
Damage-dependent regulation of MUS81-EME1 by Fanconi anemia complementation group A protein
Benitez, A., Yuan, F., Nakajima, S., Wei, L., Qian, L., Myers, R. S., Hu, J. J., Lan, L., & Zhang, Y. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt975 · Cited by 15
Cherubini, G., Naim, V., Caruso, P., Burla, R., Bogliolo, M., Cundari, E., Benihoud, K., Saggio, I., & Rosselli, F. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr084 · Cited by 15
Emerging roles for centromere-associated proteins in DNA repair and genetic recombination
Osman, F., & Whitby, M. C. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130200 · Cited by 15
Lin, M., Eng, C., Hawk, E. T., Huang, M., Lin, J. M., Gu, J. H., Ellis, L. M., & Wu, X. (2012) · Cancer · doi:10.1002/cncr.27653 · Cited by 16
The phenotype of FancB-mutant mouse embryonic stem cells
Kim, T. M., Ko, J. H., Choi, Y. J., Hu, L., & Hasty, P. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.03.010 · Cited by 15
Structural aspects of multi-domain RING/Ubox E3 ligases in DNA repair
Hibbert, R. G., Mattiroli, F., & Sixma, T. K. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.01.014 · Cited by 15
Shen, Y., Zhang, J., Yu, H., & Fei, P. (2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.986 · Cited by 14
Kobbe, S., Trapp, O., Knoll, A., Mannuß, A., & Puchta, H. (2015) · PLANT PHYSIOLOGY · doi:10.1104/pp.15.00806 · Cited by 14
Nucleotide Excision Repair and Response and Survival to Chemotherapy in Colorectal Cancer Patients
Kap, E. J., Popanda, O., & Chang-Claude, J. C. (2016) · Pharmacogenomics · doi:10.2217/pgs-2015-0017 · Cited by 14
Wesolowski, R., Stover, D. G., Lustberg, M. B., Shoben, A. B., Zhao, M., Mrózek, E., Layman, R. M., Macrae, E. R., Duan, W., Zhang, J., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2020-0039 · Cited by 14
Kapoor, S., Gustafson, T. A., Zhang, M., Chen, Y., Li, J., Nhung, N. T., Perez, J. E. T., Dashwood, W. M., Rajendran, P., & Dashwood, R. H. (2021) · Cancers · doi:10.3390/cancers13061438 · Cited by 15
Defects in DNA Lesion Bypass Lead to Spontaneous Chromosomal Rearrangements and Increased Cell Death
Schmidt, K. H., Viebranz, E., Harris, L., Mirzaei, H., Syed, S., & Medicus, R. (2009) · Eukaryotic Cell · doi:10.1128/ec.00260-09 · Cited by 14
The role of the Fanconi anemia network in the response to DNA replication stress
Gari, K., & Constantinou, A. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230903154150 · Cited by 14
Oxidative Stress-Associated Protein Tyrosine Kinases and Phosphatases in Fanconi Anemia
Li, J., & Pang, Q. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5715 · Cited by 14
Replication Protein A (RPA) deficiency activates the Fanconi anemia DNA repair pathway
Jang, S.-W., Jung, J. K., & Kim, J. M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1201621 · Cited by 14
Wang, L., Wang, H., Wang, T., Liu, J., Chen, W., Wang, Y., Chen, C., Zhu, H., & Dai, P. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1575846 · Cited by 14
Yamamoto, K., Nihrane, A., Aglipay, J. A., Sironi, J., Arkin, S., Lipton, J. M. M., Ouchi, T., & Liu, J. M. (2008) · Molecular Medicine · doi:10.2119/2007-00122.yamamoto · Cited by 14
Chionh, F. J. M., Mitchell, G., Lindeman, G. J., Friedlander, M. L., & Scott, C. L. (2011) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/j.1743-7563.2011.01430.x · Cited by 16
The RecQ helicase RECQL5 participates in psoralen-induced interstrand cross-link repair
Ramamoorthy, M., May, A., Tadokoro, T., Popuri, V., Seidman, M. M., Croteau, D. L., & Bohr, V. A. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt183 · Cited by 13
Cuccarolo, P., Viaggi, S., & Degan, P. (2012) · FEBS Journal · doi:10.1111/j.1742-4658.2012.08629.x · Cited by 13
Effects of Breast Cancer Genes 1 and 2 on Cardiovascular Diseases
Zhou, S., Jin, J., Wang, J., Zhang, Z., Huang, S., Zheng, Y., & Cai, L. (2019) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2019.04.001 · Cited by 13
Tokunaga, E., Okada, S., Kitao, H., Shiotani, S., Saeki, H., Endo, K., Morita, M., Kakeji, Y., & Maehara, Y. (2009) · Breast Cancer · doi:10.1007/s12282-009-0175-z · Cited by 13
Phenotyping Genetic Diseases Using an Extension of µ-Scores for Multivariate Data
Morales, J. F., Song, T., Auerbach, A. D., & Wittkowski, K. M. (2008) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1372 · Cited by 13
Papel das proteínas XPD e DNA polimerase eta nas respostas de células humanas a danos no genoma
Lerner, L. K. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2014.tde-20102014-103732 · Cited by 13
Fanconi anemia is a highly penetrant cancer susceptibility syndrome.
Dokal, I. S. (2008) · PubMed · Cited by 13
Connecting the Dots: Interplay between Ubiquitylation and SUMOylation at DNA Double-Strand Breaks
Tang, J.-B., & Greenberg, R. A. (2010) · Genes & Cancer · doi:10.1177/1947601910382774 · Cited by 12
Bezzerri, V., Api, M., Allegri, M., Fabrizzi, B., Corey, S. J., & Cipolli, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134672 · Cited by 13
Impaired function of Fanconi anemia type C-deficient macrophages
Liu, Y., Ballman, K. K., Li, D., Khan, S., Derr-Yellin, E. C., Shou, W., & Haneline, L. S. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0811418 · Cited by 12
Evolutionary genomics of human intellectual disability
Crespi, B. J., Summers, K., & Dorus, S. (2009) · Evolutionary Applications · doi:10.1111/j.1752-4571.2009.00098.x · Cited by 12
Carvunis, A., Roth, F. P., Calderwood, M. A., Cusick, M. E., Superti‐Furga, G., & Vidal, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-385944-0.00003-4 · Cited by 12
Crumbaker, M., Chan, E. K. F., Gong, T., Corcoran, N. M., Jaratlerdsiri, W., Lyons, R. J., Haynes, A., Kulidjian, A., Kalsbeek, A. M. F., Petersen, D. C., et al. (2020) · Cancers · doi:10.3390/cancers12051178 · Cited by 12
Research progress of the Fanconi anemia pathway and premature ovarian insufficiency
Zhao, J., Zhang, Y., Li, W., Yao, M., Liu, C., Zhang, Z., Wang, C., Wang, X., & Meng, K. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad110 · Cited by 11
Insights into common fragile site instability: DNA replication challenges at DNA repeat sequences
Sinai, M. I., & Kerem, B. (2023) · Emerging Topics in Life Sciences · doi:10.1042/etls20230023 · Cited by 11
Clinical implications of using molecular diagnostics for ovarian cancers
Kohn, E. C., Romano, S., & Lee, J.-M. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt464 · Cited by 11
Wang, X., Chen, G., Liu, H., Zhao, Z., & Li, Z. (2010) · Journal of Proteome Research · doi:10.1021/pr100581x · Cited by 11
Wang, Y., Han, X. Y., Wu, F., Leung, J. W. C., Lowery, M. G., Do, H., Chen, J., Shi, C., Tian, C., Li, L., et al. (2013) · Cell Research · doi:10.1038/cr.2013.124 · Cited by 11
Ko, J. H., Son, M. Y., Zhou, Q., Molnárová, L., Song, L., Mlčoušková, J., Je̅kabsons, A., Montagna, C., Krejčí, L., & Hasty, P. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108543 · Cited by 11
The role of USP 1 autocleavage in DNA interstrand crosslink repair
Kim, M., & Kim, J. M. (2016) · FEBS Letters · doi:10.1002/1873-3468.12060 · Cited by 11
Contemplating chemosensitivity of basal-like breast cancer based on BRCA1 dysfunction
Ohta, T., Wu, W., Koike, A., Asakawa, H., Koizumi, H., & Fukuda, M. (2009) · Breast Cancer · doi:10.1007/s12282-009-0115-y · Cited by 11
The role of BACH1 , BARD1 and TOPBP1 genes in familial breast cancer
Karppinen, S. (2009) · Cited by 11
Kim, J. H., Choi, D. H., Cho, D. Y., Ahn, S. H., Son, B. H., & Haffty, B. G. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0806-2 · Cited by 10
Zhang, P., Sridharan, D., & Lambert, M. W. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25352 · Cited by 10
Assembling an orchestra: Fanconi anemia pathway of repair
Yuan, F. (2010) · Frontiers in bioscience · doi:10.2741/3666 · Cited by 10
Nuclear alpha spectrin: Critical roles in DNA interstrand cross-link repair and genomic stability
Lambert, M. W. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216662714 · Cited by 10
Inherited Bone Marrow Failure Syndromes
Canham, L. E., & de Jong, J. L. O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00131-1 · Cited by 10
Thompson, L. H., & Jones, N. J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.003 · Cited by 10
Lu, W.-T., Lemonidis, K., Drayton, R. M., & Nouspikel, T. (2011) · Cell Cycle · doi:10.4161/cc.10.19.17178 · Cited by 10
Meindl, A. (2009) · Breast Care · doi:10.1159/000211991 · Cited by 9
Walker, L. C., Thompson, B. A., Waddell, N., kConFab Investigators, Grimmond, S. M., & Spurdle, A. B. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000850 · Cited by 9
Sugahara, R., Mon, H., Lee, J. M., & Kusakabe, T. (2012) · Gene · doi:10.1016/j.gene.2012.03.071 · Cited by 9
A Protein Prioritization Approach Tailored for the FA/BRCA Pathway
Haitjema, A., Brandt, B. W., Ameziane, N., May, P., Heringa, J., de Winter, J. P., Joenje, H., & Dorsman, J. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062017 · Cited by 9
Hovest, M. G., Krieg, T. M., & Herrmann, G. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01365.x · Cited by 9
Sun, G. Z., Noronha, A. M., & Wilds, C. J. (2012) · Tetrahedron · doi:10.1016/j.tet.2012.07.043 · Cited by 9
Embryonic Lethality after Combined Inactivation of Fancd2 and Mlh1 in Mice
van de Vrugt, H. J., Eaton, L., Newell, A. H., Al-Dhalimy, M., Liskay, R. M., Olson, S. B., & Grompe, M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2452 · Cited by 9
A FANCD2 domain activates Tip60‐dependent apoptosis
Hejna, J., Bruun, D. A., Pauw, D., & Moses, R. E. (2010) · Cell Biology International · doi:10.1042/cbi20090251 · Cited by 9
Nicoletto, M. O., Bertorelle, R., Borgato, L., Salvo, G. L. D., Artioli, G., Lombardi, G., Zustovich, F., Marcato, R., Parenti, A. R., Montagna, M., et al. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181a83cb5 · Cited by 9
TOPBP1 , CLSPN and PALB2 genes in familial breast cancer susceptibility
Erkko, H. (2008) · Cited by 9
Bloom Syndrome Radials Are Predominantly Non-Homologous and Are Suppressed by Phosphorylated BLM
Owen, N. M., Hejna, J., Rennie, S., Mitchell, A., Newell, A. H., Ziaie, N., Moses, R. E., & Olson, S. B. (2014) · Cytogenetic and Genome Research · doi:10.1159/000375247 · Cited by 8
Joaquin, A., & Fernández-Capetillo, Ó. (2012) · InTech eBooks · doi:10.5772/50863 · Cited by 14
Munari, F. M., Guecheva, T. N., Bonatto, D., & Henriques, J. A. P. (2013) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2013.09.003 · Cited by 8
Identification of FANCA as a protein interacting with centromere-associated protein E
Du, J., Chen, L., & Shen, J. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp074 · Cited by 9
Malumbres, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00004-9 · Cited by 10
Paiboonsukwong, K., Ohbayashi, F., Shiiba, H., Aizawa, E., Yamashita, T., & Mitani, K. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1382 · Cited by 8
Metadata
- Authors
- Wang, W.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Wang, Weidong
- ORCID
- Wang, Weidong
- Venue
- Nature Reviews Genetics
- Published
- 2007-10
- Volume
- 8
- Issue
- 10
- Pages
- 735-748
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- OpenAlex
- W2010216792
- Cited by
- 663
- References
- 107
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 11 · 2023: 5 · 2022: 15 · 2021: 10 · 2020: 17 · 2019: 20 · 2018: 12 · 2017: 28 · 2016: 24 · 2015: 31 · 2014: 40 · 2013: 52 · 2012: 52
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- Fanconi anemia, BRCA genes, DNA damage response, genome stability, BRCA2, FANCJ, FANCI, PALB2, BRIP1, ATR, Bloom syndrome protein, BRCA1, signal transduction, DNA repair, breast cancer susceptibility
- MeSH terms
- Fanconi Anemia Complementation Group N Protein, Animals, Chromatin, DNA, DNA Damage, DNA Repair, DNA-Binding Proteins, Fanconi Anemia, Humans, Nuclear Proteins, Signal Transduction, RNA Helicases, BRCA2 Protein, Tumor Suppressor Proteins, Ubiquitin-Protein Ligases, Fanconi Anemia Complementation Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review